This annual award was instituted in 1996, and from 2002 – 2005 was sponsored by AstraZeneca (and known as the AstraZeneca Medal). From 2006- 2015, the award was again known as the ASTH Medal and between 2016 and 2023 it was known as the THANZ Medal. It is now known as the THANZ Claire McLintock Medal.
The award is intended for early to mid-career individuals working actively in clinical and laboratory research in the field of thrombosis and haemostasis. The award is judged on the basis of an oral presentation from a short list selected on abstract merit. The award winner receives the THANZ Claire McLintock Medal, a solid silver medallion, and a prize of A$2,000. In addition, there are two runner up awards of A$500 each.
- The entrant must be aged ≤ 45 (on the closing day of Blood) or a clinician/scientist at an early stage in their career (within 10 years of completion of PhD or clinical sub-specialty training) and a member of THANZ
- The entrant must be a clinician, nurse, scientist or technologist working actively in the field of thrombosis and haemostasis and must be the main author and presenter of the abstract
- Previous winners of the Medal and invited speakers are ineligible
- All eligiable abstracts submitted via the Blod online portal will be considered for short-listing
Applications will be judged, by a panel of experts drawn from the THANZ membership, on the basis of a) abstracts submitted for the annual meeting and b) an oral presentation. For those entrants submitting posters, there will be an opportunity to present their work to the judging panel. The winner will be announced at the Gala Dinner.
Further information can be obtained from the award organiser:
THANZ Secretariat
PO Box77
Brunswick South LPO
West Brunswick
Vic 3055
Phone: +61 3 9388 9876
Email: [email protected]